CTOs on the Move

Alkeus Pharmaceuticals, Inc.

www.alkeuspharma.com

 
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company developing transformative therapeutics to address serious, progressive eye diseases that lead to blindness. Our lead compound, ALK-001, is an oral investigational drug being developed for the treatment of Stargardt disease (STGD) and Geographic Atrophy (GA) secondary to dry age-related macular degeneration. ALK-001 is a selectively-deuterated form of Vitamin A that slows the dimerization of Vitamin A, which is implicated in STGD, and has shown statistically-significant and clinically-meaningful efficacy in the TEASE-1 Phase 2 clinical trial. Based on these results, ALK-001 has been granted Breakthrough Therapy Designation for the treatment of Stargardt Disease.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

MILLER MARINE

MILLER MARINE is a National City, CA-based company in the Business Services sector.

C. H. Nevin

C. H. Nevin is a Chagrin Falls, OH-based company in the Business Services sector.

c-shell

c-shell is a Metuchen, NJ-based company in the Business Services sector.

TMone

TMone is a Iowa City, IA-based company in the Business Services sector.

Paramount Performance Marketing

Paramount Performance Marketing is a Jacksonville, FL-based company in the Business Services sector.